Log In
BCIQ
Print this Print this
 

Verigene Respiratory Virus Plus Nucleic Acid Test (RV+)

  Manage Alerts
Collapse Summary General Information
Company Luminex Corp.
DescriptionIn vitro diagnostic to detect influenza A and influenza B, subtypes of influenza A, and respiratory syncytial virus (RSV) A and B infections
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationInfectious, Diagnostic
Indication DetailsDetect influenza A and influenza B, identify H1, H3 and 2009 H1N1 subtypes of influenza A, and detect respiratory syncytial virus (RSV) A and B infections
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$58.0M

$58.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/30/2016

$58.0M

$58.0M

0

Get a free BioCentury trial today